DDIS-26. HIGH-THROUGHPUT DRUG SCREENING OF MENINGIOMAS IDENTIFIES HDAC INHIBITORS AS PROMISING TARGETS ACROSS GRADES

Meningiomas are a common central nervous system (CNS) tumor, accounting for one third of CNS neoplasms. To date, no FDA approved pharmacotherapy exists for meningiomas. In an effort to identify potential treatments for meningiomas we created a culture system that allows us to grow and screen tumors...

Full description

Saved in:
Bibliographic Details
Published in:Neuro Oncol
Main Authors: Tatman, Philip, Fringuello, Anthony, Wroblewski, Teddy, Scherer, Sam, Foreman, William, Ryan Ormond, D, Damek, Denise, Lillehei, Kevin, Jensen, Randy, Graner, Michael
Format: Artigo
Language:Inglês
Published: Oxford University Press 2019
Subjects:
Drug Discovery
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847367/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.277
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items